Takeda Pharmaceutical Limited
TAK | NYSE
$19
+$0.11 (+0.58%)
Sep 22, 2026, 11:36 AM ET · Market open
Market Data
Market Cap $60.11B
Enterprise Value $14.18T
Beta 0.09
Average Volume 3.18M
Shares Outstanding (Diluted) 3.21B
Shares Change YoY 1.04%
Institutional Ownership 3.12%
Exchange NYSE
ISIN US8740602052
Price Performance
Price Change 1M 3.6%
Price Change 3M 19.3%
Price Change 6M 3.3%
Price Change YTD 20.9%
Price Change 1Y 25.9%
Price Change 3Y 19.3%
Price Change 5Y 11.8%
1M CAGR (ann.) 8.3%
1Y CAGR (ann.) 30.8%
5Y CAGR (ann.) 6.6%
All-Time CAGR 1.8%
Valuation
PE Ratio 51.53
Forward PE 48.03
PEG Ratio 1.70
Forward PEG 0.87
PS Ratio 1.99
Forward PS 2.00
PB Ratio 1.29
P/FCF Ratio 15.69
P/Adj. FCF Ratio 17.24
P/OCF Ratio 10.17
EV/Sales 3.04
EV/EBIT 23.99
EV/EBITDA 11.18
EV/FCF 24.01
Earnings Yield 1.9%
FCF Yield 6.2%
Adj. FCF Yield 5.7%
Financial Health
Net Debt ¥4.41T
Total Debt ¥4.94T
Cash & Short-Term Investments ¥527.58B
Total Assets ¥15.66T
Current Ratio 1.14
Quick Ratio 0.62
Debt / Equity Ratio 0.65
Debt / EBITDA 3.90
Debt / FCF 8.36
OCF / Debt 0.20
Interest Coverage 1.55
Altman Z-Score 1.23
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 62.1%
Operating Profit Margin 11.0%
EBITDA Margin 27.2%
Net Profit Margin 3.9%
FCF Margin 12.7%
Adj. FCF Margin 11.5%
SBC / Revenue 1.2%
SBC Impact (per share) -9.0%
Returns
Return on Assets 1.1%
Return on Equity 2.4%
Return on Invested Capital 2.4%
Return on Capital Employed 3.8%
Return on Tangible Assets 2.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 4.3%
Revenue CAGR 5Y 6.8%
Revenue CAGR 10Y 10.0%
EPS CAGR 3Y -16.1%
EPS CAGR 5Y -16.3%
EPS CAGR 10Y -6.4%
FCF CAGR 3Y 19.8%
FCF CAGR 5Y -5.3%
FCF CAGR 10Y 10.5%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y 28.0%
Revenue Growth Next 3Y 1.5%
Earnings Date Oct 28, 2026
EPS Estimate (next Q) $0
EPS Growth Est (next Q) -692.9%
Revenue Est (next Q) $46.34M
Revenue Growth Est (next Q) 1.2%
Fair Value Estimates
Graham Number $10.79
Graham Upside -42.9%
Lynch Fair Value $1.83
Lynch Upside -90.3%
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow ¥986.56B
Free Cash Flow ¥590.62B
Adj. Free Cash Flow ¥537.56B
FCF Per Share $224.07
OCF Per Share $286.35
OCF/S Ratio 19.4%
Income Statement
Revenue ¥4.66T
Gross Profit ¥2.75T
Operating Income ¥512.02B
EBITDA ¥1.27T
Net Income ¥182.14B
EPS (Diluted) $56.53
Revenue / Employee $99.1M
Profit / Employee $3.87M
Employees 47,029
Dividends
Annual Dividend $0.63
Dividend Yield 3.34%
Payout Ratio 1.1%
FCF Payout Ratio 51.6%
Adj. FCF Payout Ratio 56.7%
Dividend Growth (YoY) 4.7%
Pay Frequency Semi-Annual
Ex-Dividend Date Mar 30, 2026
Add to Watchlist
Select watchlists to add or remove TAK